Wilson Sonsini's patents and innovations attorneys are experts in global patent portfolio development and management for a variety of life sciences clients, including start-up and established biotechnology corporations, multinational pharmaceutical corporations, and premier research universities.
Wilson Sonsini's patents and innovations professionals are responsible for developing the IP portfolios covering such inventions as CRISPR gene-editing, the DNA chip, cancer therapies, nanotechnology, cell-free genetic tests, medical devices, stem cell technologies, and next-generation DNA sequencing. Our attorneys work with innovators engaged in highly technical fields, including diagnostics, genomics, bioinformatics, artificial intelligence, and materials.
Many of Wilson Sonsini's 160-plus patent attorneys and patent agents possess Ph.D.s or other advanced degrees in biology, chemistry, biomedical sciences, or engineering.
Over 130 of Wilson Sonsini's attorneys and agents have been admitted to practice before the USPTO. Our team includes several former USPTO executives, including a former Administrative Patent Judge, a former Deputy Administrator in the Office of Policy and External Affairs, a former Deputy Commissioner for Patent Operations, and a former Deputy Commissioner for Patent Administration.
Wilson Sonsini's patents and innovations practice helps clients leverage their intellectual property, defend against claims of others, and establish a competitive position for the future in fields such as therapeutics, biologics, personalized medicine, research tools, and clean technologies. Our team helps growing companies achieve important milestones by securing, developing, and protecting their most vital IP assets, while also advising established companies responsible for advancing groundbreaking discoveries. We identify the areas in which IP protection is most critical to achieving the company's business objectives, determine the most effective methods of protection, and identify strategies to avoid issues with third-party patents.
The members of Wilson Sonsini's patents and innovations team are experts in all facets of IP counseling, including the following:
Wilson Sonsini's patents and innovations team is comprised of more than 170 experienced patent attorneys and patent agents. In 2023, the firm had more than 840 U.S. and 2,060 foreign patents issued on behalf of clients.
Wilson Sonsini has an impressive track record of IP value creation, as members of our practice are responsible for the development of the IP portfolios covering such inventions as CRISPR gene editing, the DNA chip, cancer therapies, nanotechnology, cell-free genetic tests, medical devices, stem cell technologies, and next-generation DNA sequencing. Our patents and innovations attorneys serve clients in the following fields:
|
|
Wilson Sonsini's patents and innovations team—which is highly integrated with the firm's corporate, litigation, and transactional practices—is comprised of more than 170 experienced patent attorneys and patent agents, most of whom possess Ph.D. or other advanced degrees in such areas as biology, chemistry, immunology, biomedical sciences, engineering, or other scientific fields.
Over 130 of Wilson Sonsini's attorneys and agents have been admitted to practice before the U.S. Patent and Trademark Office. In fact, our team includes several former USPTO executives, including a former Administrative Patent Judge, a former Deputy Administrator in the Office of Policy and External Affairs, a former Deputy Commissioner for Patent Operations, and a former Deputy Commissioner for Patent Administration.
Wilson Sonsini's patents and innovations practice helps clients leverage their intellectual property, defend against claims of others, and establish a competitive position for the future in fields such as therapeutics, biologics, personalized medicine, research tools, and clean technologies. Our team helps growing companies achieve important milestones by securing, developing, and protecting their most vital IP assets, while also advising established companies responsible for advancing groundbreaking discoveries. We identify the areas in which IP protection is most critical to achieving the company's business objectives, determine the most effective methods of protection, and identify strategies to avoid issues with third-party patents.
The members of Wilson Sonsini's patents and innovations team are experts in all facets of IP counseling, including the following:
Wilson Sonsini's patents and innovations team is comprised of more than 170 experienced patent attorneys and patent agents. In 2023, the firm had more than 840 U.S. and 2,060 foreign patents issued on behalf of clients.
Wilson Sonsini has an impressive track record of IP value creation, as members of our practice are responsible for the development of the IP portfolios covering such inventions as CRISPR gene editing, the DNA chip, cancer therapies, nanotechnology, cell-free genetic tests, medical devices, stem cell technologies, and next-generation DNA sequencing. Our patents and innovations attorneys serve clients in the following fields:
|
|
Wilson Sonsini's patents and innovations team—which is highly integrated with the firm's corporate, litigation, and transactional practices—is comprised of more than 170 experienced patent attorneys and patent agents, most of whom possess Ph.D. or other advanced degrees in such areas as biology, chemistry, immunology, biomedical sciences, engineering, or other scientific fields.
Over 130 of Wilson Sonsini's attorneys and agents have been admitted to practice before the U.S. Patent and Trademark Office. In fact, our team includes several former USPTO executives, including a former Administrative Patent Judge, a former Deputy Administrator in the Office of Policy and External Affairs, a former Deputy Commissioner for Patent Operations, and a former Deputy Commissioner for Patent Administration.
Dr. Lin practices IP law and focuses on the pharmaceutical, life sciences, and biotech fields.
Dr. Lin practices IP law and focuses on the pharmaceutical, life sciences, and biotech fields.